Clinical Trial Update: The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Steri3X aiming to prevent postoperative wound infections in cesarean sections; current status unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Postpartum Complications
• Postpartum Infection
• Surgical Site Infection

Drugs mentioned

• Steri3X

Snippet

Sponsor: University of Tennessee | Conditions: Surgical Site Infection, Cesarean Section; Complications, Wound, Infection (Following Delivery) | Phase 2 | Status: UNKNOWN